SCHEMBL25703026

SCHEMBL25703026

c1ccc(-c2ccc3[nH]c4c(ccc5oc6ccccc6c54)c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.46
▸ PLA2G4A P47712 4/20 0.46
▸ CASP3 P42574 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ GABRP O00591 1/20 0.44
▸ GABRD O14764 1/20 0.44
▸ GABRA1 P14867 1/20 0.44
▸ GABRB1 P18505 1/20 0.44
▸ GABRG2 P18507 1/20 0.44
▸ GABRB3 P28472 1/20 0.44
▸ GABRA5 P31644 1/20 0.44
▸ GABRA3 P34903 1/20 0.44
▸ GABRA2 P47869 1/20 0.44
▸ GABRB2 P47870 1/20 0.44
▸ GABRA4 P48169 1/20 0.44
▸ GABRE P78334 1/20 0.44
▸ GABRA6 Q16445 1/20 0.44
▸ GABRG1 Q8N1C3 1/20 0.44
▸ GABRG3 Q99928 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25678769 0.94 KDM4E (0.45) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL17381199 0.90 GABRP (0.43) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL15127073 0.90 KDM4E (0.48) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL15126676 0.90 GABRP (0.49) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL25704008 0.85 GABRP (0.39) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL16745243 0.85 PLA2G2A (0.50) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL25689073 0.84 CDK4 (0.51) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL16310389 0.83 CDK4 (0.42) PLA2G2APLA2G4ACASP3SENP7SENP6
SCHEMBL29520332 0.83 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12105369 0.83 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240298538-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2024-09-05 — — US disclosed
CN-117412976-A Compound, light-emitting material, and light-emitting element 九州有机光材股份有限公司 2024-01-16 — — CN disclosed
US-20230210000-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE KYULUX, INC. (JP) 2023-06-29 — — US disclosed
WO-2022249506-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT 株式会社Kyulux 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210000-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE DRD1, DRD2, DRD3 PLA2G2A 3535/4885PLA2G4A 3787/4885CASP3 3750/4885
US-20240298538-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CRY2, TPH1 PLA2G2A 4081/4885PLA2G4A 3948/4885CASP3 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback